PATENT CLAIM ANALYSIS

Application Number: 16267102
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "255040"]

Abstract:
A method for the treatment and/or prevention of pain which comprises administering to a subject in need of such treatment a therapeutically effective amount of 1-(3-4(((1R,3S,5S)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazine and pharmaceutically acceptable salts thereof (“AV1066”), with reference to visceral and neuropathic pain.

Claim (Index 4):
The method of  claim 1 , comprising administering the AV1066 in a dosage of from about 250 mg/day to about 1000 mg/day.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 99.0
- Lexical Diversity: 1.37778
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15340311', '14351113', '14513887', '13347136', '12068006']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.693266174702847
- 35 USC 102 Novelty (BERT): 0.5741274181455304
- Combined Prediction Score: 0.6813522990471154
- Mean Citation Score: 251.726004
- Max Citation Score: 437.58493
- Similarity Product: 427.2329206855864

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test